$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The top ten contraindications of F/TAF and the risks and precautions that must be avoided when taking it
2026-02-01 22:25:32
Check Details
The dosage and usage specifications of Febuxostat (Febuxostat) and the adjustment plan according to the patient's condition
2026-02-01 22:25:32
Check Details
Furmonertinib side effects usually begin to appear within a few days and analysis of symptoms
2026-02-01 22:25:32
Check Details
Safety precautions and contraindications you need to pay attention to while taking ensifentrine-Ohtuvayre
2026-02-01 22:25:32
Check Details
Why is it not recommended to take Roaccutane (Isotretinoin) at night? Choose the medication time scientifically
2026-02-01 22:25:32
Check Details
Is doxorubicin hydrochloride a chemotherapy drug? Introduction to drug categories and common combination regimens
2026-02-01 22:25:32
Check Details
Which groups of people are not suitable for taking everolimus (Afinitor)?
2026-02-01 22:25:32
Check Details
How long does it take for estramustine (Adelox) to take effect?
2026-02-01 22:25:32
Check Details
Interactions between Seripalase (BRINEURA) and other drugs and description of risks of combined use
2026-02-01 22:25:32
Check Details
How effective is Eslicarbazepine in treating epilepsy? Patient feedback summary
2026-02-01 22:25:32
Check Details
Which patients are suitable for dabrafenib combined with trametinib? Read the price, indications and side effects in one article
2026-02-01 22:25:32
Check Details
How much does a box of Quizartinib cost? Market reference
2026-02-01 22:25:32
Check Details
1
2
...
2212
2213
2214
2215
2216
2217
2218
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
2
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
3
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
4
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
5
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
6
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
7
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
8
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
9
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
10
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
11
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
12
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment